Takeda Pharmaceutical Co. Ltd. · TSE:4502
Furuta Milano received 12,300 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Furuta Milano (Director, Chief Financial Officer) received 12,300 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 70,200 shares. Filed Jul 6, 2026 (Form 4).
- Awarded
- 12,300 shares
- Holding after
- 70,200 shares
- Trading plan
- No
- Role
- Director, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Ordinary Shares | Award | 12,300 | 70,200 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Furuta Milano
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Furuta Milano · Apr 28, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026